Pneumocystis Carinii Pneumonia Associated with Low Dose Methotrexate Treatment for Rheumatoid Arthritis

1 January 1994

journal article
research article
Published by Taylor & Francis in Scandinavian Journal of Rheumatology

Vol. 23 (1) , 51-53
https://doi.org/10.3109/03009749409102137

Abstract

Since 1983 there have been several reports on Pneumocystis carinii pneumonia (PCP), complicating low dose methotrexate (MTX) therapy for rheumatoid arthritis (RA). Two additional cases of this opportunistic infection are reported and a review of the literature on the complication is presented. It is concluded that PCP is a serious complication of low dose MTX therapy for RA and should always be ruled out when a patient presents with pulmonary symptoms. Several factors may play a role in the occurrence of this opportunistic infection, but the exact mechanism has not yet been elucidated.

Keywords

This publication has 6 references indexed in Scilit:

PNEUMOCYSTIS CARINII INFECTION COMPLICATING CYTOTOXIC THERAPY IN TWO PATIENTS WITH LYMPHOPENIA, BUT A NORMAL TOTAL WHITE CELL COUNT
Rheumatology, 1992
Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for rheumatoid arthritis.
Thorax, 1991
Methotrexate: Mechanism of action in rheumatoid arthritis
Seminars in Arthritis and Rheumatism, 1990
Rheumatoid Arthritis, Methotrexate Therapy, and Pneumocystis Pneumonia
Annals of Internal Medicine, 1990
Pneumocystis carinii pneumonia following methotrexate therapy for rheumatoid arthritis
Arthritis & Rheumatism, 1983